Literature DB >> 18337636

Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients.

Josep M Mercader1, Fernando Fernández-Aranda, Mònica Gratacòs, Marta Ribasés, Anna Badía, Cynthia Villarejo, Raquel Solano, Juan R González, Julio Vallejo, Xavier Estivill.   

Abstract

BACKGROUND: Evidence of a role of brain-derived neurotrophic factor (BDNF) in the pathophysiology of eating disorders (ED) has been provided by association studies and by murine models. BDNF plasma levels have been found altered in ED and in psychiatric disorders that show comorbidity with ED. AIMS: Since the role of BDNF levels in ED-related psychopathological symptoms has not been tested, we investigated the correlation of BDNF plasma levels with the Symptom Checklist 90 Revised (SCL-90R) questionnaire in a total of 78 ED patients.
METHODS: BDNF levels, measured by the enzyme-linked immunoassay system, and SCL-90R questionnaire, were assessed in a total of 78 ED patients. The relationship between BDNF levels and SCL-90R scales was calculated using a general linear model.
RESULTS: BDNF plasma levels correlated with the Global Severity Index and the Positive Symptom Distress Index global scales and five of the nine subscales in the anorexia nervosa patients. BDNF plasma levels were able to explain, in the case of the Psychoticism subscale, up to 17% of the variability (p = 0.006).
CONCLUSION: Our data suggest that BDNF levels could be involved in the severity of the disease through the modulation of psychopathological traits that are associated with the ED phenotype. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337636     DOI: 10.1159/000120623

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  14 in total

Review 1.  Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

Authors:  Timothy D Brewerton
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa.

Authors:  Stefan Ehrlich; Harriet Salbach-Andrae; Sarah Eckart; Julia V Merle; Roland Burghardt; Ernst Pfeiffer; Leonora Franke; Ralf Uebelhack; Ulrike Lehmkuhl; Rainer Hellweg
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

Review 3.  The lighter side of BDNF.

Authors:  Emily E Noble; Charles J Billington; Catherine M Kotz; ChuanFeng Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-23       Impact factor: 3.619

4.  Correlation of BDNF blood levels with interoceptive awareness and maturity fears in anorexia and bulimia nervosa patients.

Authors:  J M Mercader; F Fernández-Aranda; Mònica Gratacòs; Zaida Aguera; Laura Forcano; Marta Ribasés; Cynthia Villarejo; Xavier Estivill
Journal:  J Neural Transm (Vienna)       Date:  2010-03-02       Impact factor: 3.575

5.  BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders.

Authors:  Carmen Gamero-Villarroel; Inmaculada Gordillo; Juan Antonio Carrillo; Angustias García-Herráiz; Isalud Flores; Mercedes Jiménez; Melchora Monge; Raquel Rodríguez-López; Guillermo Gervasini
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-11-29       Impact factor: 4.785

6.  Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders.

Authors:  C Gamero-Villarroel; L María González; I Gordillo; J Antonio Carrillo; A García-Herráiz; I Flores; R Rodríguez-López; G Gervasini
Journal:  Pharmacogenomics J       Date:  2014-09-23       Impact factor: 3.550

7.  Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum; Mark Gold
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-30

Review 8.  Eating disorders: the current status of molecular genetic research.

Authors:  Susann Scherag; Johannes Hebebrand; Anke Hinney
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-12-24       Impact factor: 4.785

9.  Genetic variants in dopamine pathways affect personality dimensions displayed by patients with eating disorders.

Authors:  Luz M González; Sonia Mota-Zamorano; Angustias García-Herráiz; Estefanía López-Nevado; Guillermo Gervasini
Journal:  Eat Weight Disord       Date:  2019-11-30       Impact factor: 4.652

10.  Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index.

Authors:  A Hinney; M Kesselmeier; S Jall; A-L Volckmar; M Föcker; J Antel; I M Heid; T W Winkler; S F A Grant; Y Guo; A W Bergen; W Kaye; W Berrettini; H Hakonarson; B Herpertz-Dahlmann; M de Zwaan; W Herzog; S Ehrlich; S Zipfel; K M Egberts; R Adan; M Brandys; A van Elburg; V Boraska Perica; C S Franklin; M H Tschöp; E Zeggini; C M Bulik; D Collier; A Scherag; T D Müller; J Hebebrand
Journal:  Mol Psychiatry       Date:  2016-05-17       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.